Characteristics of the treatment of perennial allergic rhinitis in patients of the older age group
https://doi.org/10.21518/2079-701X-2018-20-107-110
Abstract
Recent studies show that perennial allergic rhinitis is prevalent among older people, but the management of this disease is underestimated and not determined. This article describes the persistent allergic rhinitis in patients of the older age group and identifies the primary goals of treatment based on the age-related physiological factors, concomitant conditions and the use of other drugs. Special attention is paid to the various options for the drug therapy in elderly patients over the age of 60 years. The second-generation antihistamines and intranasal glucocorticosteroids also have primacy over other drugs, when supervising older patients. A randomized open multicenter clinical study showed that Momate Rhino Advance (a combination of intranasal antihistamines (azelastine) and intranasal glucocorticosteroids (mometasone) for the treatment of allergic rhinitis) made by Indian Glenmark Pharmaceuticals Ltd. is effective and safe in patients aged 60 years and older, who are diagnosed with the above disease.
About the Authors
K. I. Sapova
Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Health of Russia, St. Petersburg
Russian Federation
Russian Federation
S. V. Ryazantsev
Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech of the Ministry of Health of Russia, St. Petersburg
Russian Federation
Russian Federation
References
1. Belan EB, Sadchikova TL. Allergic rhinitis: current approaches to diagnosis and treatment. Lekarstvennyy Vestnik, 2017, 11 (3): 3-10.
2. Bodnya OS, Nenasheva NM, Andrenova GV, Sinyavkin DO, et al. Comparative efficacy of various second-generation antihistamines in adult patients with seasonal allergic rhinitis. Consilium Medicum, 2017, 19 (3): 101-108.
3. Kamaev AV, Trusova OV, Lyashenko NL. Evaluation of the clinical efficacy of nasal filters in the complex therapy of patients with persistent allergic rhinitis. Rossiyskaya Otorinolaringologia, 2017, 3: 130-137.
4. Masalsky SS, Smolkin YuS. Antihistamines in the treatment of allergic rhinitis. Allergologia i Immunologia v Pediatrii, 2018, 2 (53).
5. Nenasheva NM. Treatment of allergic rhinitis through the spectacle of new international guidelines: the role of topical combination therapy. Effektivnaya Farmakoterapia, 2018, 6: 40-49.
6. Nenasheva NM. The role of modern antihistamine drugs in the treatment of allergic diseases. Rossiyskiy Allergologicheskiy Zhurnal, 2017, 14 (4-5): 80-88.
7. Yudina SM, et al. Features of local and systemic mechanisms of allergic inflammation in seasonal allergic rhinitis. Kurskiy Nauchno-Prakticheskiy Vestnik “Chelovek i Ego Zdorovie”, 2018, 2.
8. Bozek А. Pharmacological Management of Allergic Rhinitis in the Elderly. Drugs & Aging, 2017, 34(1): 21–28.
9. Blomme K., Tomassen P., Lapeere H., Huvenne W. еt al. Prevalence of allergic sensitization versus allergic rhinitis symptoms in an unselected population. Internernational Archieve of Allergy and Immunology, 2013, 160(200): 207.
10. Bousquet P.J., Demoly P., Devillier P., Mesbah K. et al. Impact of allergic rhinitis symptoms on quality of life in primary care. Internernational Archieve of Allergy and Immunology, 2013, 160(393): 400.
11. Mullol J., Bartra J., del Cuvillo A., Izquierdo I. et al. Specialist- based treatment reduces the severity of allergic rhinitis. Clinical Allergology, 2013, 43(723): 729.
12. Wallace D.V., Dykewicz M.S., Bernstein D.I., Blessing-Moore J. et al. The diagnosis and management of rhinitis: an updated practice parameter. Journal of Allergy and Clinical Immunology, 2008, 122(S1): 84.
Review
For citations:
Sapova KI, Ryazantsev SV. Characteristics of the treatment of perennial allergic rhinitis in patients of the older age group. Meditsinskiy sovet = Medical Council. 2018;(20):107-110. (In Russ.) https://doi.org/10.21518/2079-701X-2018-20-107-110
Views:
1230
Email this article 